A novel murine model of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) induced by immunization with a spermine binding protein (p25) peptide.
The pathophysiology of chronic prostatitis/chronic pelvic pain syndrome (CP/CPPS) is poorly understood. Inflammatory and autoimmune mechanisms may play a role. We developed a murine model of experimental autoimmune prostatitis (EAP) that mimics the human phenotype of CP/CPPS. Eight-week-old mice were immunized subcutaneously with prostate-specific peptides in an emulsion of complete Freund's adjuvant. Mice were euthanized 10 days after immunization, and lymph node cells were isolated and assessed for recall proliferation to each peptide. P25 99-118 was the most immunogenic peptide. T-cell and B-cell immunity and serum levels of C-reactive protein and nitrate/nitrite levels were evaluated over a 9-wk period. Morphometric studies of prostate, 24-h micturition frequencies, and urine volume per void were evaluated. Tactile referred hyperalgesia was measured using von Frey filaments to the pelvic region. The unpaired Student's t-test was used to analyze differences between EAP and control groups. Prostates from p25 99-118-immunized mice demonstrated elevated gene expression levels of TNF-α, IL-17A, IFN-γ, and IL-1β, not observed in control mice. Compared with controls, p25 99-118-immunized mice had significantly higher micturition frequency and decreased urine output per void, and they demonstrated elevated pelvic pain response. p25 99-118 immunization of male SWXJ mice induced prostate-specific autoimmunity characterized by prostate-confined inflammation, increased micturition frequency, and pelvic pain. This autoimmune prostatitis model provides a useful tool for exploring the pathophysiology and new treatments.
Department of Urology, University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, OH 44106, USA.
Cengiz Z
CZ
Altuntas
Firouz
F
Daneshgari
Elias
E
Veizi
Kenan
K
Izgi
Fuat
F
Bicer
Ahmet
A
Ozer
Kerry O
KO
Grimberg
Bakytzhan
B
Bakhautdin
Cagri
C
Sakalar
Cemal
C
Tasdemir
Vincent K
VK
Tuohy
D000818:Animals; D001327:Autoimmune Diseases / Q000276:immunology; D002352:Carrier Proteins / Q000276:immunology*; D002908:Chronic Disease; D059350:Chronic Pain / Q000276:immunology* / Q000473:pathology; D004195:Disease Models, Animal; D007114:Immunization / Q000379:methods; D020381:Interleukin-17 / Q000378:metabolism; D008297:Male; D051379:Mice; D017699:Pelvic Pain / Q000276:immunology* / Q000473:pathology; D010446:Peptide Fragments / Q000276:immunology; D011467:Prostate / Q000276:immunology; D011472:Prostatitis / Q000276:immunology* / Q000473:pathology; D014409:Tumor Necrosis Factor-alpha / Q000378:metabolism
D002352:Carrier Proteins; D020381:Interleukin-17; D010446:Peptide Fragments; D014409:Tumor Necrosis Factor-alpha; C025957:spectrin-binding proteins